Litcius/Paper detail

Nanodrug shows spatiotemporally controlled release of anti-PD-L1 antibody and STING agonist to effectively inhibit tumor progression after radiofrequency ablation

Huanling Guo, Jinsheng Huang, Tan Yang, Wenxin Wu, Tongyi Huang, Nan Zhang, Shuling Chen, Chunyang Zhang, Xiaoyan Xie, Xintao Shuai, Ming Xu

2022Nano Today37 citationsDOI

Topics & Concepts

StingCancer researchTumor microenvironmentMedicineImmune systemImmunotherapyImmune checkpointAgonistTumor progressionImmunopotentiatorCytotoxic T cellBlockadeCD8PharmacologyCancerImmunologyInternal medicineChemistryReceptorIn vitroAerospace engineeringEngineeringBiochemistryCancer Immunotherapy and Biomarkersinterferon and immune responsesImmunotherapy and Immune Responses